Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells

Qasim, 2014, Progress and prospects for engineered T cell therapies, Br. J. Haematol., 166, 818, 10.1111/bjh.12981 Sadelain, 2013, The basic principles of chimeric antigen receptor design, Cancer Discov., 3, 388, 10.1158/2159-8290.CD-12-0548 Lorentzen, 2015, CD19-chimeric antigen receptor t cells for treatment of chronic lymphocytic leukaemia and acute lymphoblastic leukaemia, Scand. J. Immunol., 82, 307, 10.1111/sji.12331 Porter, 2015, Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia, Sci. Transl. Med., 7, 303ra139, 10.1126/scitranslmed.aac5415 Maude, 2014, Chimeric antigen receptor T cells for sustained remissions in leukemia, N. Engl. J. Med., 371, 1507, 10.1056/NEJMoa1407222 Turtle, 2016, CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients, J. Clin. Invest., 126, 2123, 10.1172/JCI85309 Abou-El-Enein, 2016, Putting a price tag on novel autologous cellular therapies, Cytotherapy, 18, 1056, 10.1016/j.jcyt.2016.05.005 Wang, 2016, Clinical manufacturing of CAR T cells: foundation of a promising therapy, Mol Ther Oncolytics, 3, 16015, 10.1038/mto.2016.15 Kebriaei, 2016, Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells, J. Clin. Invest., 126, 3363, 10.1172/JCI86721 Torikai, 2016, Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors, Mol. Ther., 24, 1178, 10.1038/mt.2016.106 Afzali, 2007, Allorecognition and the alloresponse: clinical implications, Tissue Antigens, 69, 545, 10.1111/j.1399-0039.2007.00834.x Poirot, 2015, Multiplex genome-edited T-cell manufacturing platform for “off-the-shelf” adoptive T-cell immunotherapies, Cancer Res., 75, 3853, 10.1158/0008-5472.CAN-14-3321 Torikai, 2012, A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR, Blood, 119, 5697, 10.1182/blood-2012-01-405365 Valton, 2015, A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy, Mol. Ther., 23, 1507, 10.1038/mt.2015.104 Boissel, 2014, megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering, Nucleic Acids Res., 42, 2591, 10.1093/nar/gkt1224 Osborn, 2016, Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases, Mol. Ther., 24, 570, 10.1038/mt.2015.197 Hacein-Bey-Abina, 2003, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1, Science, 302, 415, 10.1126/science.1088547 Hacein-Bey-Abina, 2008, Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1, J. Clin. Invest., 118, 3132, 10.1172/JCI35700 Braun, 2014, Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity, Sci. Transl. Med., 6, 227ra33, 10.1126/scitranslmed.3007280 Ellis, 2005, Silencing and variegation of gammaretrovirus and lentivirus vectors, Hum. Gene Ther., 16, 1241, 10.1089/hum.2005.16.1241 Schumann, 2015, Generation of knock-in primary human T cells using Cas9 ribonucleoproteins, Proc. Natl. Acad. Sci. USA, 112, 10437, 10.1073/pnas.1512503112 Hirsch, 2014, AAV-mediated gene editing via double-strand break repair, Methods Mol. Biol., 1114, 291, 10.1007/978-1-62703-761-7_19 Miller, 2003, Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks, Mol. Cell. Biol., 23, 3550, 10.1128/MCB.23.10.3550-3557.2003 Moser, 2016, AAV Vectorization of DSB-mediated Gene Editing Technologies, Curr. Gene Ther., 16, 207, 10.2174/1566523216666160602213738 Sather, 2015, Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template, Sci. Transl. Med., 7, 307ra156, 10.1126/scitranslmed.aac5530 Wang, 2016, Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery, Nucleic Acids Res., 44, e30, 10.1093/nar/gkv1121 Seligman, 2002, Mutations altering the cleavage specificity of a homing endonuclease, Nucleic Acids Res., 30, 3870, 10.1093/nar/gkf495 Djukanovic, 2013, Male-sterile maize plants produced by targeted mutagenesis of the cytochrome P450-like gene (MS26) using a re-designed I-CreI homing endonuclease, Plant J., 76, 888, 10.1111/tpj.12335 Ménoret, 2013, Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases, FASEB J., 27, 703, 10.1096/fj.12-219907 Grizot, 2009, Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease, Nucleic Acids Res., 37, 5405, 10.1093/nar/gkp548 Cradick, 2014, COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites, Mol. Ther. Nucleic Acids, 3, e214, 10.1038/mtna.2014.64 Imai, 2004, Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia, Leukemia, 18, 676, 10.1038/sj.leu.2403302 Dykes, 2007, Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults, Transfusion, 47, 2134, 10.1111/j.1537-2995.2007.01438.x Schumm, 2013, Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device, Cytotherapy, 15, 1253, 10.1016/j.jcyt.2013.05.014 Sahin, 2014, mRNA-based therapeutics--developing a new class of drugs, Nat. Rev. Drug Discov., 13, 759, 10.1038/nrd4278 Hastie, 2015, Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective, Hum. Gene Ther., 26, 257, 10.1089/hum.2015.025 Torikai, 2013, Toward eliminating HLA class I expression to generate universal cells from allogeneic donors, Blood, 122, 1341, 10.1182/blood-2013-03-478255 ClinicalTrials.gov (2016). Study of UCART19 in Pediatric Patients with Relapsed/Refractory B Acute Lymphoblastic Leukemia (PALL). https://clinicaltrials.gov/ct2/show/NCT02808442. Stoddard, 2014, Homing endonucleases from mobile group I introns: discovery to genome engineering, Mob. DNA, 5, 7, 10.1186/1759-8753-5-7 Si, 2010, A strand invasion 3′ polymerization intermediate of mammalian homologous recombination, Genetics, 185, 443, 10.1534/genetics.110.115196 Vasileva, 2005, Precise hit: adeno-associated virus in gene targeting, Nat. Rev. Microbiol., 3, 837, 10.1038/nrmicro1266 Grieger, 2006, Production and characterization of adeno-associated viral vectors, Nat. Protoc., 1, 1412, 10.1038/nprot.2006.207 Hoyos, 2010, Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety, Leukemia, 24, 1160, 10.1038/leu.2010.75